Jaime Rosenberg

Project Baseline, launched a year ago in April, was brought to life by Duke University School of Medicine, Verily, Stanford Medicine, and Google to better understand the transition from health to disease and shift healthcare in the United States from reactive to proactive.

Atezolizumab, in combination with chemotherapy, significantly reduced the risk of disease progression and mortality in patients with metastatic triple-negative breast cancer.

Following a federal judge’s decision to block Kentucky's Medicaid work requirements on Friday, Republican Governor Matt Bevin has cut Medicaid dental and vision benefits for 460,000 Medicaid enrollees. The Cabinet for Health and Family Services called the decision "an unfortunate consequence of the judge’s ruling."

According to Amgen and Novartis, their calcitonin gene-related peptide inhibitor has demonstrated safety and efficacy in a 1-year study in chronic migraine and reinforced safety and tolerability in a 3-year interim analysis from an ongoing 5-year study in episodic migraine.

African Americans are still disproportionately affected by HIV compared with other ethnic groups.

We've rounded up the top 5 most read articles of June, including trial results from the 2018 American Society of Clinical Oncology Annual Meeting and a FDA breakthrough therapy designation for a gene therapy.

The American Medical Group Association has endorsed a set of 14 value measurements to streamline the reporting process and reduce costs while also improving care by offering a standard set of measures for value-based contracts with payers.

While it is known that heightened estrogen levels are linked to an increased prevalence of migraine in women, new research suggests that the hormone plays an equally important role in causing migraine among men.

As tomorrow marks National HIV Testing Day, over 400 organizations and clinics nationwide are spearheading efforts to promote testing.

HHS Secretary Alex Azar appeared before the Senate Committee on Finance today to discuss the Trump administration’s efforts to drive drug innovation and affordability, answering a slew of questions revolving around the "American Patients First" blueprint, increasing generic and biosimilar competition, and value-based pricing.

First-line treatment with atezolizumab plus chemotherapy helped patients with previously untreated extensive-stage small cell lung cancer (SCLC) live significantly longer than those treated with chemotherapy alone.

Providing an alternative to inpatient care, hospital-at-home care bundled with a 30-day postacute transitional care episode is associated with improved patient outcomes, such as readmissions and emergency department revisits, and ratings of care compared with inpatient hospitalization.

Many people at high risk of getting HIV—including those who inject drugs, gay and bisexual men, and partners of people with HIV—are not screened annually and experience delays in diagnosis.

FDA action; gene discover in ALL

For people living with HIV who achieve viral suppression from antiretroviral therapy, there is a reduced risk of developing both AIDS-defining cancer and non-AIDS-defining cancer.

Amazon, Berkshire Hathaway, and JPMorgan Chase have tapped Atul Gawande, MD, general and endocrine surgeon at Brigham and Women’s Hospital, and professor of surgery at Harvard T.H. Chan School of Public Health and Harvard Medical School, to become the chief executive officer of their healthcare company, effective July 9.

Coverage of the latest clinical updates in cancer research.

Just 3 in 10 patients who experienced a nonfatal opioid overdose (OD) were given follow-up medication to prevent another overdose, and the average treatment lasted less than 6 months.

Employers that offer healthcare benefits, paid sick days, and disability insurance benefits will spend about $84,000 in annual migraine-related costs for every 1000 employees.

While the majority of physicians generally believe that social determinants of health, such as food insecurity and housing instability, matter for their patients, they do not believe that it is their responsibility to address them and do not feel well positioned to do so.

Despite behavioral migraine treatment being effective, safe, and well-tolerated, less than one-third of eligible patients are referred for treatment and only half of those referred initiate treatment.

The FDA has approved the first generic version of Suboxone (buprenorphine and naloxone) sublingual film as medication-assisted treatment for those with opioid use disorder.

The Paxman Scalp Cooling System is now indicated to reduce the likelihood of chemotherapy-induced alopecia in patients with solid tumors, such as ovarian, breast, colorectal, bowel, and prostate cancer.

While the pilot study successfully explored the efficacy of timolol eyedrops, further research is necessary to identify patients who would benefit the most from this treatment and an appropriate dosage.

On National HIV Testing Day on June 27, Walgreens and Greater Than AIDS will partner with over 200 health and community organizations to provide free HIV testing and information at Walgreens stores in over 180 cities.

The 70 National Cancer Institute (NCI)-designated cancer centers underscored the importance of increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the human papillomavirus (HPV).

Between 2008 and 2016, primary care providers increasingly relied on nurse practitioners amidst a shortage of doctors, especially in rural areas.

Farmers, gardeners, and mountain guides—all at a greater risk for nonmelanoma skin cancer (NMSC) due to increased solar ultraviolet radiation exposure—participate in varying risk and protective behaviors, and have different risks for NMSC.

With more states in the works for introducing and passing Medicaid work requirements, and states with approved bills preparing to implement them, here are 5 updates to know about.

New study results have concluded that antiretroviral therapy (ART) initiation within 30 days of HIV diagnosis is associated with a significantly reduced risk of treatment dropout and failure.